
| Pair Name | Zerumbone, Nimesulide | ||
| Phytochemical Name | Zerumbone (PubChem CID: 5470187 ) | ||
| Anticancer drug Name | Nimesulide (PubChem CID: 4495 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Zerumbone, Nimesulide | |||
| Disease Info | [ICD-11: 2B90.Z] | Colon cancer | Investigative | |
| Gene Regulation | Down-regulation | Expression | COX2 | hsa4513 |
| In Vivo Model | Acute colitis was induced by exposing female ICR mice to 5% DSS in drinking water for 1 week. One week prior to DSS administration, the experimental mice were fed ZER alone, nimesulide (NIM, a selective COX-2 inhibitor) alone, or both in combination (1000 ppm each) for a total of 2 weeks. | |||
| Result | Our results suggest that ZER is a novel food factor for mitigating experimental UC and that use of a combination of agents, with different modes of actions, may be an effective anti-inflammatory strategy. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Suppression of dextran sodium sulfate-induced colitis in mice by zerumbone, a subtropical ginger sesquiterpene, and nimesulide: separately and in combination. Biochem Pharmacol. 2003 Oct 1;66(7):1253-61. doi: 10.1016/s0006-2952(03)00446-5. | Click |